Results 271 to 280 of about 9,643,208 (350)
The Parkinson's disease death rate: carbidopa and vitamin B6
Marty Hinz, Alvin Stein, Ted Cole
openalex +2 more sources
“Time Is Brain” – for Cell Therapies
The concept that “time is brain” extends to stem cell therapy for stroke. Evidence across preclinical and clinical studies indicates that delivery timing shapes graft survival, integration, and efficacy by matching the evolving post‐stroke microenvironment.
Hao Yin +4 more
wiley +1 more source
Lower Urinary Tract Symptoms Correlation With Motor and Cognitive Function in Patients With Parkinson Disease. [PDF]
Golesorkhi N +3 more
europepmc +1 more source
Microglial GPR35 Ameliorates Epileptogenesis and Neuroinflammation via PDGFA Domain 2 Signaling
Activation of microglial G protein–coupled receptor 35 (GPR35) by L‐kynurenic acid (L‐Kyna) initiates a platelet‐derived growth factor A (PDGFA)–dependent phosphoinositide 3‐kinase–protein kinase B (PI3K–AKT) signaling cascade that dampens hippocampal neuroinflammation, thereby restraining epileptogenesis, lowering seizure susceptibility, and ...
Qi Wang +17 more
wiley +1 more source
Parkinson Disease <i>SNCA</i> Risk Variants Are Associated With Higher Asymmetric Putamen Dopaminergic Dysfunction. [PDF]
Alhusaini S +6 more
europepmc +1 more source
Parkinsonism as an initial presentation of Creutzfeldt‐Jakob disease: A case report and review of literature [PDF]
S. Bahrami +3 more
openalex +1 more source
This review introduces the development and classification of all‐nanozyme cascade reaction systems, highlighting mechanistic insights and research methods for understanding catalytic features and design principles. It provides detailed classifications, surveys recent applications in biosensing and therapy, and discusses the challenges that all‐nanozyme
Caixia Zhu +4 more
wiley +1 more source
Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes. [PDF]
Fiorini MR +4 more
europepmc +1 more source

